News
Life Molecular Imaging Receives FDA Fast Track Approval for (18F)PI-2620 in Tau PET Imaging in Three Neurodegenerative Diseases
Fast-track status granted for use in patients being evaluated for Alzheimer’s disease, progressive supranuclear palsy or corticobasal degeneration BOSTON, 28
4 Minute